Cargando…

Physical activity in chronic obstructive pulmonary disease: clinical impact and risk factors

Detalles Bibliográficos
Autor principal:	Shin, Kyeong-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768551/ https://www.ncbi.nlm.nih.gov/pubmed/29334725 http://dx.doi.org/10.3904/kjim.2017.387

Ejemplares similares

Energy expenditure as a marker of physical activity intensity in chronic obstructive pulmonary disease
por: Orme, Mark W
Publicado: (2021)

Identifying prognostic factors in chronic obstructive pulmonary disease patients
por: García-Sanz, María-Teresa
Publicado: (2017)

Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017)

Pulmonary Rehabilitation after a Chronic Obstructive Pulmonary Disease Exacerbation: Impact on Readmission Risk in a Real-World Setting
por: Nici, Linda
Publicado: (2021)

Comorbid Chronic Obstructive Pulmonary Disease and Heart Failure: Shared Risk Factors and Opportunities to Improve Outcomes
por: Khan, Sadiya S., et al.
Publicado: (2022)

Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease: Can IMPACT Help?
por: Suissa, Samy
Publicado: (2020)

Clinical impact of forced vital capacity on exercise performance in patients with chronic obstructive pulmonary disease
por: Moon, Seong Mi, et al.
Publicado: (2021)

Smoking cessation and chronic obstructive pulmonary disease
por: Yoo, Kwang Ha
Publicado: (2015)

Metabolic syndrome and chronic obstructive pulmonary disease
por: Koul, Parvaiz A
Publicado: (2016)

Diaphragmatic dysfunction in chronic obstructive pulmonary disease
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

The Complex Beginnings of Chronic Obstructive Pulmonary Disease
por: Guerra, Stefano, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease: The Present and Future
por: Krishnan, Aditya, et al.
Publicado: (2022)

Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)

Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions
por: Yawn, Barbara P., et al.
Publicado: (2023)

Are Adults with Chronic Obstructive Pulmonary Disease Vulnerable to Air Pollution and Cardiovascular Risk?
por: Pope III, C. Arden
Publicado: (2021)

Clinical Impacts of Interventions for Physical Activity and Sedentary Behavior on Patients with Chronic Obstructive Pulmonary Disease
por: Tashiro, Hiroki, et al.
Publicado: (2023)

Effects of TNF-α and Leptin on Weight Loss in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Shin, Kyeong-Cheol, et al.
Publicado: (2007)

The Autonomous Nervous System: A Novel and Potentially Modifiable Risk Factor for Chronic Obstructive Pulmonary Disease in the Population?
por: Hamrefors, Viktor
Publicado: (2023)

Understanding the People Excluded from Chronic Obstructive Pulmonary Disease Clinical Trials
por: Krishnan, Jamuna K., et al.
Publicado: (2022)

What Affects Chronic Obstructive Pulmonary Disease in Korea?
por: Cho, Hae-Wol, et al.
Publicado: (2016)

High prevalence of chronic obstructive pulmonary disease in Korea
por: Rhee, Chin Kook
Publicado: (2016)

Drugging the Mighty Neutrophil in Chronic Obstructive Pulmonary Disease
por: Fessler, Michael B.
Publicado: (2019)

Validation of Imaging Measures in Chronic Obstructive Pulmonary Disease
por: Aaron, Carrie Pistenmaa, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease and Work: Is It Time to Stop?
por: Halpin, David
Publicado: (2019)

Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time
por: Calverley, Peter M. A., et al.
Publicado: (2019)

The Saga of Necroptosis in Chronic Obstructive Pulmonary Disease Continues
por: Racanelli, Alexandra C., et al.
Publicado: (2021)

The Paradox of Obesity in Patients with Chronic Obstructive Pulmonary Disease
por: Yohannes, Abebaw Mengistu
Publicado: (2022)

The role of quantitative imaging in chronic obstructive pulmonary disease
por: Wada, Danilo Tadao
Publicado: (2022)

Predicting Pneumonia in Chronic Obstructive Pulmonary Disease. Have We Unraveled the Network of Risks?
por: Dransfield, Mark T., et al.
Publicado: (2020)

The Air We Breathe: Respiratory Impact of Indoor Air Quality in Chronic Obstructive Pulmonary Disease
por: Mkorombindo, Takudzwa, et al.
Publicado: (2022)

Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea
por: Yum, Ho-Kee, et al.
Publicado: (2017)

Mind the Gap: Addressing Cardiovascular Disease in Chronic Obstructive Pulmonary Disease
por: Wells, J. Michael, et al.
Publicado: (2022)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Jo, Yong Suk, et al.
Publicado: (2021)

Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease
por: Feng, Han-Rong, et al.
Publicado: (2018)

The double jeopardy of chronic obstructive pulmonary disease and myocardial infarction
por: Sinha, Shashank S, et al.
Publicado: (2014)

Chronic obstructive pulmonary disease: Indian guidelines and the road ahead
por: Koul, Parvaiz A.
Publicado: (2013)

Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment
por: Clini, Enrico M., et al.
Publicado: (2014)

On Trapped Air and Trapped Blood in Chronic Obstructive Pulmonary Disease
por: Watz, Henrik
Publicado: (2019)

Antibiotic Retreatment for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Sethi, Sanjay, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mlrvai9vnaukl4orc6f7aqmulp